TREATMENT OF PARKINSON'S DISEASE

• US 3,701,829 A
• Filed: 07/09/1971
• Issued: 10/31/1972
• Est. Priority Date: 07/24/1970
• Status: Expired due to Term

• Current Assignee: Bartholini Giuseppe
• Original Assignee: Bartholini Giuseppe
• Inventors: BARTHOLINI GIUSEPPE
• Application Number:
  US05/162,028
• Time in Patent Office: 480 Days
• US Class Current: 514/563
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/15 Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
• CPC Class Codes: A61K 31/16 Amides, e.g. hydroxamic acids
• CPC Class Codes: A61K 31/195 having an amino group

Abstract

PHARMACEUTICAL COMPOSITIONS FOR TREATING PARKINSON'"'"''"'"'S DISEASE WHICH CONTAIN AS THE ACTIVE ANTI-PARKINSONISM INGREDIENT, L-3-(4-HYDROXY-3-METHOXYPHENYL)-ALANINE, OR A HYDRATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND AS AN OPTIONAL INGREDIENT, A PERIPHERAL DECARBOXYLASE INHIBITOR, ARE DESCRIBED. THE COMPOSITIONS ARE USEFUL FOR THE TREATMENT OF PARKINSON'"'"''"'"'S DISEASE WITH LITTLE OR NONE OF THE SIDE-EFFECTS USUALLY ASSOCIATED WITH L-DOPA.

Claims